• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔鳞状细胞癌患者治疗结果与生存率的回顾性分析

Retrospective Analysis of Treatment Outcomes and Survival Rates in Oral Squamous Cell Carcinoma Patients.

作者信息

Kukreja Pankaj, Grewal Raman, Tejaswee Annaluru Sri Sasank, Sharma Sanjeev, Maini Anuj Paul, Chandran Thara, Gulia Sunil Kumar

机构信息

Department of Biomedical Dental Sciences, Faculty of Dentistry, Al-Baha University, Al-Aqiq Campus, Kingdom of Saudi Arabia.

Advance Cancer Institute, Bathinda, Punjab, India.

出版信息

J Pharm Bioallied Sci. 2024 Jul;16(Suppl 3):S2440-S2442. doi: 10.4103/jpbs.jpbs_297_24. Epub 2024 Jul 31.

DOI:10.4103/jpbs.jpbs_297_24
PMID:39346248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11426841/
Abstract

BACKGROUND

Because of its high rates of morbidity and death, oral squamous cell carcinoma (OSCC) poses a serious threat to world health. To maximize patient care and direct clinical decision-making, it is important to comprehend treatment results and survival rates.

METHODS

Treatment results and survival rates for OSCC patients treated at a tertiary care facility between 2010 and 2022 were assessed in this retrospective research. Demographic data, tumor features, treatment options, and follow-up results were all included in the data. The relationships between treatment methods and survival rates were evaluated by statistical analysis.

RESULTS

There were 107 OSCC patients in all. Compared to radiation and chemotherapy, surgery had reduced recurrence rates and greater overall survival rates as the most common treatment option. There were notable variations in survival rates across the various treatment regimens ( < 0.05).

CONCLUSION

Surgery is the mainstay. Adjuvant treatments, however, are complementary in the management of illness. The significance of customized treatment strategies based on unique patient attributes and tumor features is highlighted by this study in order to maximize results for patients with OSCC. To confirm these results and investigate cutting-edge treatment approaches, more investigation is necessary.

摘要

背景

口腔鳞状细胞癌(OSCC)因其高发病率和死亡率,对全球健康构成严重威胁。为了最大限度地提高患者护理水平并指导临床决策,了解治疗结果和生存率非常重要。

方法

本回顾性研究评估了2010年至2022年在一家三级医疗机构接受治疗的OSCC患者的治疗结果和生存率。数据包括人口统计学数据、肿瘤特征、治疗选择和随访结果。通过统计分析评估治疗方法与生存率之间的关系。

结果

共有107例OSCC患者。作为最常见的治疗选择,与放疗和化疗相比,手术降低了复发率,提高了总生存率。不同治疗方案的生存率存在显著差异(<0.05)。

结论

手术是主要治疗方法。然而,辅助治疗在疾病管理中具有辅助作用。本研究强调了基于患者独特属性和肿瘤特征制定个性化治疗策略的重要性,以便为OSCC患者实现最佳治疗效果。为了证实这些结果并研究前沿治疗方法,还需要更多的研究。

相似文献

1
Retrospective Analysis of Treatment Outcomes and Survival Rates in Oral Squamous Cell Carcinoma Patients.口腔鳞状细胞癌患者治疗结果与生存率的回顾性分析
J Pharm Bioallied Sci. 2024 Jul;16(Suppl 3):S2440-S2442. doi: 10.4103/jpbs.jpbs_297_24. Epub 2024 Jul 31.
2
Improved recurrence rates and progression-free survival in primarily surgically treated oral squamous cell carcinoma - results from a German tertiary medical center.主要经手术治疗的口腔鳞状细胞癌的复发率和无进展生存率提高 - 来自德国三级医疗中心的结果。
Clin Oral Investig. 2024 Apr 20;28(5):262. doi: 10.1007/s00784-024-05644-z.
3
Locally advanced oral squamous cell carcinoma patients treated with photobiomodulation for prevention of oral mucositis: retrospective outcomes and safety analyses.局部晚期口腔鳞状细胞癌患者接受光生物调节预防口腔黏膜炎的治疗:回顾性结果和安全性分析。
Support Care Cancer. 2018 Jul;26(7):2417-2423. doi: 10.1007/s00520-018-4046-z. Epub 2018 Feb 8.
4
Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients.115例T1-T2期口腔鳞状细胞癌患者的临床病理参数、复发情况、局部区域及远处转移情况
Head Neck Oncol. 2010 Apr 20;2:9. doi: 10.1186/1758-3284-2-9.
5
Evaluating the Efficacy of Adjuvant Radiotherapy in the Management of Advanced Oral Cancer Cases.评估辅助放疗在晚期口腔癌病例管理中的疗效。
J Pharm Bioallied Sci. 2024 Jul;16(Suppl 3):S2727-S2729. doi: 10.4103/jpbs.jpbs_299_24. Epub 2024 Jun 7.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
Prospective evaluation of outcome after transoral CO(2) laser resection of T1/T2 oral squamous cell carcinoma.经口二氧化碳激光切除T1/T2期口腔鳞状细胞癌术后结局的前瞻性评估
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Aug;112(2):180-7. doi: 10.1016/j.tripleo.2010.09.078. Epub 2011 Jan 12.
8
Evaluation of factors associated with the risk stratification of survivorship for stage IV squamous cell carcinoma of the oral cavity: A 10-year retrospective study.评估与口腔 IV 期鳞状细胞癌生存风险分层相关的因素:一项 10 年回顾性研究。
J Chin Med Assoc. 2020 May;83(5):491-499. doi: 10.1097/JCMA.0000000000000292.
9
Comprehensive Analysis of Oral Squamous Cell Carcinomas: Clinical, Epidemiological, and Histopathological Insights With a Focus on Prognostic Factors and Survival Time.口腔鳞状细胞癌的综合分析:临床、流行病学和组织病理学见解,重点关注预后因素和生存时间
Cureus. 2024 Feb 18;16(2):e54394. doi: 10.7759/cureus.54394. eCollection 2024 Feb.
10
Prognostic effect of surgical treatment in elderly oral squamous cell carcinoma patients: A retrospective study.老年口腔鳞状细胞癌患者手术治疗的预后效果:一项回顾性研究。
Oral Oncol. 2024 Jul;154:106849. doi: 10.1016/j.oraloncology.2024.106849. Epub 2024 May 14.

引用本文的文献

1
Identification of glycolysis-related genes and analysis of potential prognostic clinical application in oral squamous cell carcinoma.口腔鳞状细胞癌中糖酵解相关基因的鉴定及潜在预后临床应用分析
Transl Cancer Res. 2025 Jun 30;14(6):3797-3811. doi: 10.21037/tcr-2025-998. Epub 2025 Jun 23.
2
Exploring the role of PANoptosis related genes in the prognosis of oral squamous cell carcinoma subtypes based on multi-omics analysis.基于多组学分析探究PAN凋亡相关基因在口腔鳞状细胞癌亚型预后中的作用。
Discov Oncol. 2025 Jul 11;16(1):1305. doi: 10.1007/s12672-025-03154-2.

本文引用的文献

1
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.纳武利尤单抗用于复发性头颈部鳞状细胞癌
N Engl J Med. 2016 Nov 10;375(19):1856-1867. doi: 10.1056/NEJMoa1602252. Epub 2016 Oct 8.
2
Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer.择期性与治疗性颈清扫术在淋巴结阴性口腔癌中的应用。
N Engl J Med. 2015 Aug 6;373(6):521-9. doi: 10.1056/NEJMoa1506007. Epub 2015 May 31.
3
Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology.口腔鳞状细胞癌及其前驱病变:流行病学与病因学
Periodontol 2000. 2011 Oct;57(1):19-37. doi: 10.1111/j.1600-0757.2011.00401.x.
4
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.头颈部癌化疗的荟萃分析(MACH-NC):93项随机试验及17346例患者的最新情况
Radiother Oncol. 2009 Jul;92(1):4-14. doi: 10.1016/j.radonc.2009.04.014. Epub 2009 May 14.
5
Platinum-based chemotherapy plus cetuximab in head and neck cancer.铂类化疗联合西妥昔单抗治疗头颈癌。
N Engl J Med. 2008 Sep 11;359(11):1116-27. doi: 10.1056/NEJMoa0802656.
6
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.放疗联合西妥昔单抗治疗头颈部鳞状细胞癌。
N Engl J Med. 2006 Feb 9;354(6):567-78. doi: 10.1056/NEJMoa053422.
7
Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.局部晚期头颈癌术后放疗联合或不联合同步化疗
N Engl J Med. 2004 May 6;350(19):1945-52. doi: 10.1056/NEJMoa032641.
8
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.同步放化疗用于晚期喉癌的器官保留治疗
N Engl J Med. 2003 Nov 27;349(22):2091-8. doi: 10.1056/NEJMoa031317.